Trust Company of Vermont’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $603K | Sell |
9,775
-50
| -0.5% | -$3.06K | 0.03% | 240 |
|
|
2025
Q3 | $613K | Hold |
9,825
| – | – | 0.03% | 240 |
|
|
2025
Q2 | $785K | Buy |
9,825
+700
| +8% | +$58.5K | 0.04% | 206 |
|
|
2025
Q1 | $784K | Sell |
9,125
-439
| -5% | -$36K | 0.04% | 201 |
|
|
2024
Q4 | $747K | Sell |
9,564
-362
| -4% | -$28.1K | 0.04% | 208 |
|
|
2024
Q3 | $716K | Sell |
9,926
-1,096
| -10% | -$77.6K | 0.04% | 202 |
|
|
2024
Q2 | $759K | Buy |
11,022
+1,721
| +19% | +$117K | 0.04% | 193 |
|
|
2024
Q1 | $675K | Sell |
9,301
-1,025
| -10% | -$68.5K | 0.04% | 204 |
|
|
2023
Q4 | $632K | Sell |
10,326
-5,418
| -34% | -$322K | 0.04% | 192 |
|
|
2023
Q3 | $900K | Sell |
15,744
-3,917
| -20% | -$237K | 0.06% | 179 |
|
|
2023
Q2 | $1.17M | Sell |
19,661
-2,155
| -10% | -$129K | 0.08% | 171 |
|
|
2023
Q1 | $1.37M | Sell |
21,816
-1,201
| -5% | -$75K | 0.1% | 158 |
|
|
2022
Q4 | $1.44M | Sell |
23,017
-1,822
| -7% | -$104K | 0.11% | 154 |
|
|
2022
Q3 | $1.24M | Sell |
24,839
-3,558
| -13% | -$197K | 0.1% | 152 |
|
|
2022
Q2 | $1.67M | Sell |
28,397
-3,932
| -12% | -$217K | 0.13% | 138 |
|
|
2022
Q1 | $1.71M | Sell |
32,329
-6,231
| -16% | -$360K | 0.12% | 142 |
|
|
2021
Q4 | $2.34M | Sell |
38,560
-827
| -2% | -$49.1K | 0.15% | 130 |
|
|
2021
Q3 | $2.21M | Buy |
39,387
+342
| +0.9% | +$18.8K | 0.16% | 130 |
|
|
2021
Q2 | $2.04M | Buy |
39,045
+8,541
| +28% | +$410K | 0.14% | 132 |
|
|
2021
Q1 | $1.34M | Buy |
30,504
+5,788
| +23% | +$243K | 0.1% | 155 |
|
|
2020
Q4 | $861K | Buy |
24,716
+3,636
| +17% | +$129K | 0.07% | 169 |
|
|
2020
Q3 | $768K | Sell |
21,080
-357
| -2% | -$13.3K | 0.07% | 168 |
|
|
2020
Q2 | $805K | Sell |
21,437
-3,017
| -12% | -$121K | 0.08% | 165 |
|
|
2020
Q1 | $897K | Buy |
24,454
+3,356
| +16% | +$130K | 0.08% | 160 |
|
|
2019
Q4 | $854K | Buy |
21,098
+2,130
| +11% | +$79.5K | 0.06% | 185 |
|
|
2019
Q3 | $658K | Buy |
+18,968
| New | +$625K | 0.05% | 202 |
|
|
2016
Q2 | – | Sell |
-1,099
| Closed | -$59K | – | 851 |
|
|
2016
Q1 | $59K | Hold |
1,099
| – | – | 0.01% | 368 |
|
|
2015
Q4 | $57K | Hold |
1,099
| – | – | 0.01% | 378 |
|
|
2015
Q3 | $50K | Hold |
1,099
| – | – | 0.01% | 394 |
|
|
2015
Q2 | $51K | Buy |
1,099
+65
| +6% | +$2.85K | 0.01% | 400 |
|
|
2015
Q1 | $44K | Hold |
1,034
| – | – | 0.01% | 417 |
|
|
2014
Q4 | $36K | Hold |
1,034
| – | – | 0.01% | 444 |
|
|
2014
Q3 | $33K | Hold |
1,034
| – | – | 0.01% | 457 |
|
|
2014
Q2 | $35K | Buy |
1,034
+27
| +3% | +$865 | 0.01% | 425 |
|
|
2014
Q1 | $27K | Buy |
+1,007
| New | +$29.9K | ﹤0.01% | 465 |
|
Other funds holding PBH
AI
NAMI
Trust Company of Vermont's PBH Position: Q4 2025 in Review
Trust Company of Vermont reduced its Prestige Consumer Healthcare (PBH) stake by 0.51% in Q4 2025, selling an estimated $3.06K and leaving 9,775 shares worth $603K. The position accounts for 0.03% of the portfolio, ranked #240.
Trust Company of Vermont first reported a position in PBH in Q1 2014 and has held it in 35 quarters since. The position peaked at $2.34M in Q4 2021. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.
- Trust Company of Vermont held 9,775 shares of Prestige Consumer Healthcare worth $603K as of Q4 2025.
- Trust Company of Vermont sold 50 Prestige Consumer Healthcare shares in Q4 2025, an estimated $3.06K.
- Prestige Consumer Healthcare made up 0.03% of Trust Company of Vermont's portfolio in Q4 2025, its #240 holding.
- Trust Company of Vermont first reported a position in Prestige Consumer Healthcare in Q1 2014 and has held it in 35 quarters since.
- Trust Company of Vermont's Prestige Consumer Healthcare position peaked at $2.34M in Q4 2021.
- 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.
Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.